Publications
Here you can browse the complete list of publications for studies listed on CDAS.
| Title | PubMed | Authors | Journal | Year | Studies |
|---|---|---|---|---|---|
| Genetic variants associated with circulating C-reactive protein levels and colorectal cancer survival: Sex-specific and lifestyle factors specific associations. | 34888857 | Huang Y, Hua X, Labadie JD, Harrison TA, Dai JY, Lindstrom S, Lin Y, Berndt SI, Buchanan DD, Campbell PT, Casey G, Gallinger SJ, Gunter MJ, Hoffmeister M, Jenkins MA, Sakoda LC, Schoen RE, Diergaarde B, Slattery ML, White E, Giles G, Brenner H, Chan… | Int J Cancer | 2022 | PLCO |
| Methylation-based markers of aging and lifestyle-related factors and risk of breast cancer: a pooled analysis of four prospective studies. | 36068634 | Dugué PA, Bodelon C, Chung FF, Brewer HR, Ambatipudi S, Sampson JN, Cuenin C, Chajès V, Romieu I, Fiorito G, Sacerdote C, Krogh V, Panico S, Tumino R, Vineis P, Polidoro S, Baglietto L, English D, Severi G, Giles GG, Milne RL, Herceg Z, Garcia-Closa… | Breast Cancer Res | 2022 | PLCO |
| Robust and Heterogenous Odds Ratio: Estimating Price Sensitivity for Unbought Items | Jean Pauphilet | M&SOM | 2022 | PLCO | |
| Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction. | 33398198 | Conti DV, Darst BF, Moss LC, Saunders EJ, Sheng X, Chou A, Schumacher FR, Olama AAA, Benlloch S, Dadaev T, Brook MN, Sahimi A, Hoffmann TJ, Takahashi A, Matsuda K, Momozawa Y, Fujita M, Muir K, Lophatananon A, Wan P, Le Marchand L, Wilkens LR, Steve… | Nat Genet | 2021 | PLCO |
| Genetic variants in the cholesterol biosynthesis pathway genes and risk of prostate cancer. | 33444688 | Cheng Y, Meng Y, Li S, Cao D, Ben S, Qin C, Hua L, Cheng G | Gene | 2021 | PLCO |
| Deep convolutional neural networks to predict cardiovascular risk from computed tomography. | 33514711 | Zeleznik R, Foldyna B, Eslami P, Weiss J, Alexander I, Taron J, Parmar C, Alvi RM, Banerji D, Uno M, Kikuchi Y, Karady J, Zhang L, Scholtz JE, Mayrhofer T, Lyass A, Mahoney TF, Massaro JM, Vasan RS, Douglas PS, Hoffmann U, Lu MT, Aerts HJWL | Nat Commun | 2021 | NLST |
| Wavelet decomposition facilitates training on small datasets for medical image classification by deep learning. | 33502624 | Masquelin AH, Cheney N, Kinsey CM, Bates JHT | Histochem Cell Biol | 2021 | NLST |
| Assessing Lung Cancer Absolute Risk Trajectory Based on a Polygenic Risk Model. | 33472890 | Hung RJ, Warkentin MT, Brhane Y, Chatterjee N, Christiani DC, Landi MT, Caporaso NE, Liu G, Johansson M, Albanes D, Marchand LL, Tardon A, Rennert G, Bojesen SE, Chen C, Field JK, Kiemeney LA, Lazarus P, Zienolddiny S, Lam S, Andrew AS, Arnold SM, A… | Cancer Res | 2021 | NLST |
| Chr15q25 genetic variant (rs16969968) independently confers risk of lung cancer, COPD and smoking intensity in a prospective study of high-risk smokers. | 33419953 | Hopkins RJ, Duan F, Gamble GD, Chiles C, Cavadino A, Billings P, Aberle D, Young RP | Thorax | 2021 | NLST |
| Using Prediction Models to Reduce Persistent Racial and Ethnic Disparities in the Draft 2020 USPSTF Lung Cancer Screening Guidelines. | 33399825 | Landy R, Young CD, Skarzynski M, Cheung LC, Berg CD, Rivera MP, Robbins HA, Chaturvedi AK, Katki HA | J Natl Cancer Inst | 2021 | NLST |
| Selenium Kinetics in Humans Change Following 2 years of Supplementation with Selenomethionine | Patterson BH, Combs GF Jr., Taylor PR, Patterson KY, Moler JE, Wastney ME | Front Endocrinol (Lausanne) | 2021 | Selenium | |
| Circulating adipokine concentrations and risk of five obesity-related cancers: A Mendelian randomization study. | 33038280 | Dimou NL, Papadimitriou N, Mariosa D, Johansson M, Brennan P, Peters U, Chanock SJ, Purdue M, Bishop DT, Gago-Dominquez M, Giles GG, Moreno V, Platz EA, Tangen CM, Wolk A, Zheng W, Wu X, Campbell PT, Giovannucci E, Lin Y, CCFR, Endometrial Cancer As… | Int J Cancer | 2021 | PLCO |
| Smoking Modifies Pancreatic Cancer Risk Loci on 2q21.3. | 33574088 | Mocci E, Kundu P, Wheeler W, Arslan AA, Beane-Freeman LE, Bracci PM, Brennan P, Canzian F, Du M, Gallinger S, Giles GG, Goodman PJ, Kooperberg C, Le Marchand L, Neale RE, Shu XO, Visvanathan K, White E, Zheng W, Albanes D, Andreotti G, Babic A, Baml… | Cancer Res | 2021 | PLCO |
| A multilayered post-GWAS assessment on genetic susceptibility to pancreatic cancer. | 33517887 | López de Maturana E, Rodríguez JA, Alonso L, Lao O, Molina-Montes E, Martín-Antoniano IA, Gómez-Rubio P, Lawlor R, Carrato A, Hidalgo M, Iglesias M, Molero X, Löhr M, Michalski C, Perea J, O'Rorke M, Barberà VM, Tardón A, Farré A, Muñoz-Bellvís L, C… | Genome Med | 2021 | PLCO |
| Opioid use by cancer status and time since diagnosis among older adults enrolled in the Prostate, Lung, Colorectal, and Ovarian screening trial in the United States. | 33638315 | Durham DD, Strassels SA, Pinsky PF | Cancer Med | 2021 | PLCO |
| Estimating the Impact of Extended Delay to Surgery for Stage I Non-small-cell Lung Cancer on Survival. | 33630435 | Mayne NR, Elser HC, Darling AJ, Raman V, Liou DZ, Colson YL, D'Amico TA, Yang CJ | Ann Surg | 2021 | NLST |
| Lung Cancer Screening With Low Dose Computed Tomography in Patients With and Without Prior History of Cancer in the National Lung Screening Trial. | 33581343 | Henderson LM, Durham DD, Tammemägi MC, Benefield T, Marsh MW, Rivera MP | J Thorac Oncol | 2021 | NLST |
| Combining pulmonary and cardiac computed tomography biomarkers for disease-specific risk modelling in lung cancer screening. | 33574075 | Schreuder A, Jacobs C, Lessmann N, Broeders MJM, Silva M, Išgum I, de Jong PA, Sverzellati N, Prokop M, Pastorino U, Schaefer-Prokop CM, van Ginneken B | Eur Respir J | 2021 | NLST |
| Lung cancer prediction by Deep Learning to identify benign lung nodules. | 33556604 | Heuvelmans MA, van Ooijen PMA, Ather S, Silva CF, Han D, Heussel CP, Hickes W, Kauczor HU, Novotny P, Peschl H, Rook M, Rubtsov R, von Stackelberg O, Tsakok MT, Arteta C, Declerck J, Kadir T, Pickup L, Gleeson F, Oudkerk M | Lung Cancer | 2021 | NLST |
| Do competing causes of mortality contribute to overdiagnosis in lung cancer screening? | 33445120 | Durham DD, Croswell JM, Marcus PM | Lung Cancer | 2021 | NLST |